ClinicalTrials.gg
Active, not recruitingNCT07764939Updated Sep 30, 2026

Comparative Effects of CIMT and TOT on Hand Function Recovery in Post Stroke Patients

An interventional study of Constraint-Induced Movement Therapy and Task-Oriented Training in Poststroke/CVA Hemiparesis, sponsored by Riphah International University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jul 2025, registered Jun 2026).
Updated Sep 30, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
All
01

Study summary

This controlled clinical study investigates and compares the effectiveness of CIMT and TOT in improving hand function among post-stroke patients. A total of 48 participants from hospitals in Sialkot will be randomly divided into two groups and receive a 3-week intervention consisting of 15 sessions. Outcomes will be assessed using the 9-Hole Peg Test, Jebsen-Taylor Hand Function Test, and grip strength, and the data will be analyzed using SPSS-21 under a single-blinded design.

Read the detailed description

This randomized clinical trial will compare the effects of Constraint-Induced Movement Therapy (CIMT) and Task-Oriented Training (TOT) on hand function in post-stroke patients. The study will be conducted over 11 months at Allama Iqbal Memorial Teaching Hospital and Life Care Hospital, Sialkot, with 48 participants (24 per group) recruited through convenience sampling and randomly assigned to either intervention.

Eligible participants will be stroke patients aged 45-65 years in the subacute to chronic phase (>3 months), medically stable, cognitively intact, and with minimal voluntary hand movement, while those with severe neurological, cognitive, or musculoskeletal impairments will be excluded.

Group A will receive CIMT involving restriction of the unaffected limb and intensive task-specific training, while Group B will receive TOT based on functional, task-oriented activities with progressive difficulty. Both interventions will be delivered over 3 weeks (15 sessions).

Outcomes will be measured using the 9-Hole Peg Test, Jebsen-Taylor Hand Function Test, and grip strength assessment. A single-blinded design will be used with blinded outcome assessors, and data will be analyzed using SPSS-21 to compare the effectiveness of both interventions.

02

Conditions studied

  • Poststroke/CVA Hemiparesis

Browse trials for

Keywords

  • Stroke rehabilitation, Constraint-Induced Movement Therapy, Task-Oriented Training, grip strength
03

In context

Paresis

468 studies on the registry are indexed under Paresis; 117 are open to participants now.

This study's enrollment of 48 is above the median of 37 across 420 interventional studies indexed under Paresis.

Browse Paresis studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Participants will be included if they meet the following criteria:

  • Age between 45 and 65 years
  • Both male and female participants
  • First-ever unilateral ischemic or hemorrhagic stroke confirmed by imaging
  • Stroke onset in subacute to chronic phase (>3 months post-stroke)
  • Medically stable and able to sit independently
  • Voluntary wrist extension of at least 10 degrees and finger extension of at least 10 degrees in the affected hand
  • (MMSE) score > 26
  • No significant pain or spasticity in affected upper limb (Modified Ashworth Scale \< 2)
  • Adequate sitting balance and trunk control for upper limb activities
  • Willingness and availability to complete the full intervention (3 weeks)
  • No significant musculoskeletal impairments (e.g., fractures or arthritis) affecting the upper limb

Exclusion Criteria: Participants will be excluded if they have:

  • Severe spasticity (Modified Ashworth Scale > 3) or joint contractures
  • Severe aphasia, neglect, or cognitive impairments affecting task performance
  • Recurrent or bilateral stroke
  • Severe upper limb impairment
  • Joint contractures or orthopedic limitations in the upper limb
  • Active infections, skin lesions, or wounds on the upper limb
  • Severe pain during limb movement
  • Participation in other upper limb rehabilitation programs concurrently
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Constraint-Induced Movement Therapy Group

    Participants in this group will receive Constraint-Induced Movement Therapy (CIMT) consisting of restraint of the unaffected upper limb combined with intensive task-specific training and repetitive functional exercises of the affected upper extremity for 3 weeks.

    Behavioral: Constraint-Induced Movement Therapy

  • Experimental
    Task-Oriented Training Group

    Participants will receive task-specific upper limb rehabilitation involving functional activities, bilateral tasks, object manipulation, and daily living task practice for 45-60 minutes per session, 5 days per week for 3 weeks.

    Behavioral: Task-Oriented Training

Interventions

  • BehavioralConstraint-Induced Movement Therapy

    Participants will undergo intensive upper limb rehabilitation involving shaping techniques, repetitive task practice, and restraint of the unaffected upper limb for 90% of waking hours, 5 days per week for 3 weeks. The therapy is delivered for 3 weeks (15 sessions; 5 sessions per week), with each session lasting approximately 60 minutes of structured rehabilitation training plus additional functional practice as prescribed. Activities are progressively graded and include fine motor tasks, object manipulation, and functional reaching and grasping exercises designed to promote neuroplasticity and motor recovery

    Also known as: CIMT

  • BehavioralTask-Oriented Training

    Participants will receive task-specific upper limb rehabilitation involving functional activities, bilateral tasks, object manipulation, and daily living task practice for 45-60 minutes per session, 5 days per week for 3 weeks. Each session consists of a 45-60 minute structured rehabilitation program including warm-up (ROM and stretching), task-specific training (reaching, grasping, pegboard, coin and card tasks), and bilateral functional activities with progressive difficulty and a cool-down phase. The intervention is delivered at an intensity of 5 sessions per week for 3 weeks, totaling 15 sessions.

    Also known as: TOT

06

What researchers measure

Primary outcomes

  1. Nine-Hole Peg Test (NHPT)

    The Nine-Hole Peg Test (9HPT) is a standardized and reliable assessment used to evaluate fine motor dexterity and hand function in individuals with post-stroke impairments. The test requires the participant to place nine pegs into nine holes and then remove them as quickly as possible, with each hand assessed separately. Performance is measured by the time (in seconds) required to complete the task, with shorter completion times indicating better manual dexterity and hand function, while longer times reflect greater impairment.

    Time frame: Baseline to 3 weeks

  2. Jebsen-Taylor Hand Function Test (JHFT)

    The Jebsen-Taylor Hand Function Test (JHFT) is a standardized assessment that takes approximately 15 to 45 minutes to administer and measures everyday fine and gross motor dexterity through seven timed tasks, such as writing, card turning, and object manipulation. Patients complete each task as quickly as possible with one hand at a time while the clinician records the completion time in seconds. Lower execution times indicate superior hand function, providing an efficient way to track pre- and post-treatment recovery or compare performance between limbs

    Time frame: baseline to 3 weeks

07

Study locations

1 site
  • department of physiotherapy, Allama Iqbal Memorial Teaching Hospital
    Sialkot, Punjab Province 51310, Pakistan
08

References and documents

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Oct 2026, 15 months after the start.

Of 221 non-industry interventional studies with no phase under Paresis, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 55. This study's planned 15 months is below that.

Counting every sponsor, half of 239 studies reached it within 32 months; a quarter within 13 and three quarters within 55.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Jul 2026 → Oct 2026 and completion Aug 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2026
First posted
Aug 14, 2026
StartActual
Jul 12, 2025
Primary completionEst.
Oct 2026was Jul 2026
CompletionEst.
Oct 2026was Aug 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 15, 2026→Oct 2026
Sep 30, 2026
Study completion
Aug 25, 2026→Oct 2026
Sep 30, 2026
Title
Comparative Effects of CIMT and TOT on Hand Function Recovery in Post Stroke Patients
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Primary completion Jul 15, 2026→Oct 2026
    Study completion Aug 25, 2026→Oct 2026
    Title Comparative Effects of CIMT and TOT on Hand Function Recovery in Post Stroke Patients
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07764939
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Jul 12, 2025
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Sep 30, 2026

Study contacts

Dr Shumaila Physio, MSNMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion